Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1245059

registered interest
date	20/10/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to consult with rare disease patient groups throughout the UK to ensure that the proposed Innovative Medicines Fund is able to support access to innovative medicines for rare diseases.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	106326
answer	answer is ministerial correction date of answer 04/11/2020 answer text <p>Proposals for the Innovative Medicines Fund are in development and we expect NHS England and NHS Improvement and the National Institute for Health and Care Excellence to lead an engagement exercise early next year.</p><p>The engagement exercise will involve the pharmaceutical industry, the National Health Service and associated bodies and patient groups, including those with rare diseases.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 04/11/2020 14:41:48 answering member 4380 label Biography information for Jo Churchill
tabling member	4005 label Biography information for Bob Blackman

1237036

registered interest
date	23/09/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to ensure people with dementia can have safe social contact with their family and friends during the covid-19 outbreak.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	94400
answer	answer is ministerial correction date of answer 08/10/2020 answer text <p>The Government guidance ‘Coronavirus (COVID-19): Meeting with others safely (social distancing)’ provides guidance for seeing friends and family and can be used by people living with dementia and their family and friends. The guidance is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/coronavirus-covid-19-meeting-with-others-safely-social-distancing/coronavirus-covid-19-meeting-with-others-safely-social-distancing" target="_blank">https://www.gov.uk/government/publications/coronavirus-covid-19-meeting-with-others-safely-social-distancing/coronavirus-covid-19-meeting-with-others-safely-social-distancing</a></p><p>The Government also published guidance on how people can make a support bubble with another household. The guidance is available at the following link:</p><p><a href="https://www.gov.uk/guidance/making-a-support-bubble-with-another-household" target="_blank">https://www.gov.uk/guidance/making-a-support-bubble-with-another-household</a></p><p>Local lockdown regulations exempt those providing care or assistance to a vulnerable person from the prohibition on household mixing.</p><p>In the ‘Adult social care: coronavirus (COVID-19) winter plan 2020 to 2021’, published on 18 September, we set out tightened infection prevention and control measures to enable visits to care home residents to continue safely. The plan is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/adult-social-care-coronavirus-covid-19-winter-plan-2020-to-2021" target="_blank">https://www.gov.uk/government/publications/adult-social-care-coronavirus-covid-19-winter-plan-2020-to-2021</a></p><p>We published visiting guidance on 22 July 2020 which outlined how providers, based on the views of their local Director of Public Health, could take a dynamic risk-based approach to allow visiting where safe. This guidance will shortly be updated to reflect the changes announced in the winter plan and is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/visiting-care-homes-during-coronavirus/update-on-policies-for-visiting-arrangements-in-care-homes" target="_blank">https://www.gov.uk/government/publications/visiting-care-homes-during-coronavirus/update-on-policies-for-visiting-arrangements-in-care-homes</a></p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 08/10/2020 16:37:44 answering member 4527 label Biography information for Helen Whately
tabling member	4005 label Biography information for Bob Blackman

1235501

registered interest
date	17/09/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Stem Cells: Donors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to encourage higher donor registration among mixed ethnicity donors to the UK stem cell and bone marrow register.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	91625
answer	answer is ministerial correction date of answer 12/10/2020 answer text <p>Since 2011 the Department has provided over £26.8 million in financial support to NHS Blood and Transplant and Anthony Nolan to enable the establishment of a unified United Kingdom Stem Cell Registry and improve access to, and outcomes of, stem cell donation.</p><p>This includes improving equity of access to unrelated donor stem cell transplantation for all ethnicities, including those with mixed ethnicities, through targeted recruitment to the UK Stem Cell Registry. Anthony Nolan have established a taskforce dedicated to engaging with supporters from minority ethnic backgrounds, including those with mixed ethnicities, which will co-create content and recruitment campaigns that serve and resonate with target audiences. Additionally, they are working closely with partners – such as the African Caribbean Leukaemia Trust and the Rik Basra Leukaemia Campaign - to focus recruitment in ethnically diverse areas of the UK, and to target recruitment on currently under-represented groups.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 12/10/2020 10:11:28 answering member 4527 label Biography information for Helen Whately
tabling member	4005 label Biography information for Bob Blackman

1231638

registered interest
date	04/09/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Stem Cells: Donors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to encourage higher donor registration among (a) all people and (b) mixed ethnicity donors to the UK stem cell and bone marrow register.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	85022
answer	answer is ministerial correction date of answer 28/09/2020 answer text <p>Since 2011 the Department has provided over £26.8 million in financial support to NHS Blood and Transplant and Anthony Nolan to enable the establishment of a unified United Kingdom Stem Cell Registry and improve access to, and outcomes of, stem cell donation. This includes improving equity of access to unrelated donor stem cell transplantation for black, Asian and minority ethnic (BAME) patients through targeted recruitment to the UK Stem Cell Registry.</p><p>There are now 1.6 million donors on the UK’s aligned stem cell registry which is part of a worldwide network of 76 stem cell registries, which list over 36 million donors worldwide and co-operate to match donors to patients across the globe.</p><p>Current funding includes very specific stipulations about the numbers of newly registered bone marrow donors, and the proportion of umbilical cords stored in the UK Cord Blood Bank that must be from BAME backgrounds (35-40%). There are now 1.6 million donors on the UK’s aligned stem cell registry and the proportion of BAME donors in the UK registry has gone up from 11% to 14% between 2014 and 2019. In 2018, 22% of newly registered potential donors were from BAME backgrounds.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 28/09/2020 12:34:48 answering member 4527 label Biography information for Helen Whately
tabling member	4005 label Biography information for Bob Blackman

1224453

registered interest
date	14/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Act 1983
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to bring forward legislative proposals to reform the Mental Health Act 1983; and whether he plans to make provisions on children's mental health services a central part of those legislative proposals.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	73799
answer	answer is ministerial correction date of answer 24/07/2020 answer text <p>We have committed to publishing a White Paper which will set out the Government’s response to Sir Simon Wessely’s Independent Review of the Mental Health Act 1983 and pave the way for reform of the Act.</p><p> </p><p>We will publish our White Paper as soon as it is possible to do so. We will consult publicly on our proposals and will bring forward a Bill to amend the Act when parliamentary time allows.</p><p> </p><p>The Independent Review made a number of recommendations around how the law works for children and young people. The Government will respond to these in the White Paper.</p><p> </p><p>The Mental Health Act 1983 covers the assessment, treatment and rights of people of all ages with a mental health disorder. It does not cover the provision of children’s mental health services.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 24/07/2020 14:06:48 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4005 label Biography information for Bob Blackman

1219155

registered interest
date	30/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the findings of the 2017 Office for Health Economics report entitled Comparing Access to Orphan Medicinal Products in the United Kingdom and other European countries, what steps his Department is taking to help ensure that people with rare diseases can access the latest treatments.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	66850
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>The National Institute for Health and Care Excellence (NICE) issues guidance for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources through its technology appraisal (TA) and highly specialised technologies (HST) programmes, including drugs for patients with rare diseases. 86% of NICE’s TA recommendations, and 100% of its HST recommendations, for orphan drugs have been positive since 2013.</p><p>Through the Early Access to Medicines Scheme, we are already making important drugs available to patients. So far around 1,500 patients have benefited from the scheme, which enables drugs to be used in clinical practice in parallel with later stages of the regulatory process.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 09:54:14 answering member 4380 label Biography information for Jo Churchill
tabling member	4005 label Biography information for Bob Blackman

1218760

registered interest
date	29/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking: Public Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much his Department has spent from the public purse on campaigns to promote the cessation of smoking in (a) 2018-19 and (b) 2019-20.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	66027
answer	answer is ministerial correction date of answer 13/07/2020 answer text <p>Expenditure on smoking cessation promotion by Public Health England for the periods of 2018-19 and 2019-20 are as follows: <br></p><p>2018-19: £2.16 million <br></p><p>2019-20: £1.78 million</p><p>The figures reference expenditure for advertising on television, radio, national press, regional press, out of home (outdoor), cinema, social and digital advertising.</p><p>All figures rounded to the nearest £10,000 and do not include VAT.</p><p>Recruitment advertising and media partnerships are not included. Paid search is not included.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 13/07/2020 16:02:40 answering member 4380 label Biography information for Jo Churchill
tabling member	4005 label Biography information for Bob Blackman

1218807

registered interest
date	29/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Thrombotic Thrombocytopenic Purpura
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what data his Department holds on the (a) current prevalence and (b) annual incidence of thrombotic thrombocytopenic purpura (TTP) in England; and how that data is collected.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	66028
answer	answer is ministerial correction date of answer 16/07/2020 answer text <p>The National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) records people with congenital anomalies and rare diseases across the whole of England. Data collection for rare diseases is at an early stage and currently NCARDRS does not collect data on thrombotic thrombocytopenic purpura (TTP). NCARDRS is working to expand rare disease registration and will work with interested parties to advance data collection on rare diseases including TTP.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 66029 question first answered 16/07/2020 19:58:47 answering member 4380 label Biography information for Jo Churchill
tabling member	4005 label Biography information for Bob Blackman

1218808

registered interest
date	29/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Thrombotic Thrombocytopenic Purpura
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the (a) diagnosis, (b) mortality and (c) morbidity rate of thrombotic thrombocytopenic purpura.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	66029
answer	answer is ministerial correction date of answer 16/07/2020 answer text <p>The National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) records people with congenital anomalies and rare diseases across the whole of England. Data collection for rare diseases is at an early stage and currently NCARDRS does not collect data on thrombotic thrombocytopenic purpura (TTP). NCARDRS is working to expand rare disease registration and will work with interested parties to advance data collection on rare diseases including TTP.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 66028 question first answered 16/07/2020 19:58:47 answering member 4380 label Biography information for Jo Churchill
tabling member	4005 label Biography information for Bob Blackman

1218809

registered interest
date	29/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Patients
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the UK strategy for rare diseases: implementation plan for England published on 29 January 2018, what progress the Government has made on working with providers to produce alert cards for patients with rare diseases; and whether people with thrombotic thrombocytopenic purpura (TTP) will be included in the list of those eligible to receive an alert card.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	66030
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>In 2019, NHS England identified those specialised services in which patients with rare diseases are treated and asked the 150 providers that deliver these services to self-assess against three key criteria: care coordination; alert cards; and transition. In total, 1,000 clinical teams undertook the assessment and the completion rate was 85%. Of those providers that self-assessed: 91% confirmed that there is a person responsible for coordinating the care of any patient with a rare disease; 56% confirmed that they gave each person an alert card; and 91% confirmed that they had active transition in place.</p><p>Alert cards are already used in some hospitals that treat patients with thrombotic thrombocytopenic purpura. NHS England is currently in the process of commissioning a service for patients with thrombotic thrombocytopenic purpura. Once a full, national service is established, an alert card will be rolled out across the service.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 10:07:56 answering member 4380 label Biography information for Jo Churchill
tabling member	4005 label Biography information for Bob Blackman